All studies
RecruitingTherapeutic exploratory (Phase II)Interventional

A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess the Efficacy and Safety of Daily OM-85 Treatment vs. Placebo given in Children Aged 6 Months to 5 Years with Recurrent Wheezing

Wheezing is very common in babies and young children, often triggered by simple coughs and colds. For some families, repeated wheezing episodes mean regular doctor visits, emergency trips, and courses of strong steroid medications. This study is testing an oral medicine called OM-85 (Broncho-Vaxom) to find out if it can protect young lungs. OM-85 is made from harmless pieces of inactive bacteria. It is designed to train the immune system to fight off chest bugs before they cause breathing trouble. Children taking part will receive either OM-85 or a dummy capsule (placebo) once a day for six months. Doctors will track whether the medicine cuts down the total number of wheezing attacks, reduces the need for oral steroids, and gives children more days free of symptoms. The trial will also monitor child safety through regular check-ups.

At a glance

Status
Recruiting
Phase
Therapeutic exploratory (Phase II)
Sponsor
OM Pharma SA
Enrolment target
126
Start
16 Jul 2024

What is this study about?

Many babies and young children develop a wheeze when they catch a cold or chest infection. Wheezing happens when the small breathing tubes in the lungs become narrow, swollen, and irritated. For some children, this happens over and over again throughout autumn and winter. These episodes can be scary for parents and often lead to sleepless nights, missed nursery days, and urgent visits to the GP or hospital.

This clinical trial is testing a medicine called OM-85, also known as Broncho-Vaxom. OM-85 acts a bit like a training session for the body's natural defences. It contains tiny, inactive fragments of bacteria that commonly cause respiratory infections. By introducing these harmless pieces to the body, the medicine aims to boost the child's immune system so their lungs can better resist common bugs that trigger wheezing.

To find out if OM-85 really works, the trial compares it to a placebo (a dummy treatment that looks identical but has no active ingredients). Half of the children will receive OM-85, and the other half will receive the placebo every day for six months. Neither the parents nor the study doctors will know which treatment a child is receiving until the trial finishes. This ensures the results are completely fair and unbiased.

Finding a simple daily medicine to reduce wheezing could make a huge difference to families. If OM-85 proves successful, it could mean fewer severe flare-ups, fewer courses of strong steroid medicines, and fewer hospital admissions for young children.

Key takeaways

  • Tests whether daily OM-85 capsules reduce repeated wheezing in young children.
  • Aimed at children aged between 6 months and 5 years old.
  • Treatment lasts for six months and involves either the medicine or a dummy pill.
  • Aims to cut down the need for oral steroid treatments and emergency care.
  • Taking part is voluntary and does not replace emergency rescue inhalers.

Who may be eligible?

This study is designed for babies and young children aged between 6 months and 5 years who suffer from recurrent wheezing. Recurrent wheezing means having repeated bouts of chest tightness, noisy breathing, or whistling sounds from the chest, often linked to common colds.

Both boys and girls can join. To take part, children must generally be in stable health outside of their wheezing flare-ups, and a parent or guardian must be willing to give the medicine daily and bring them to scheduled clinic visits.

Children may not be able to join if they have other serious long-term lung conditions, severe heart problems, or known immune system disorders. The study doctor will review your child's complete medical history to make sure taking part is suitable and safe for them.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. My child is aged between 6 months and 5 years.
  2. My child has had repeated bouts of wheezing or asthma-like breathing.
  3. I am able to give my child a study treatment once daily for six months.
  4. I can attend regular check-ups at the study clinic.
  5. My child does not have another major, complex lung or heart condition.
Answer every question to see your result.

What does participation involve?

If your child joins the study, they will take part for around six months. They will be given a capsule once a day to take at home. For very young children who cannot swallow capsules, the medicine can usually be opened and mixed into a small amount of liquid or soft food like yoghurt.

You will attend several clinic appointments so the medical team can check your child's health. During these visits, doctors will listen to their chest, check vital signs like temperature and heart rate, and perform gentle physical examinations. You will also be asked to keep a simple diary of any wheezy days, symptoms, and any other medications your child needs, such as inhalers or steroid liquids. If your child becomes unwell, you will have direct contact with the research team.

Potential risks and benefits

Your child might benefit from taking part if the active medicine reduces their wheezing episodes, though there is no guarantee it will help or that they will receive the active drug rather than the placebo. All children in the study receive close, expert medical supervision. OM-85 is generally well tolerated, but like any medicine, it may cause mild side effects such as an upset tummy, loose stools, or a minor skin rash. Taking part is completely voluntary. You can withdraw your child from the trial at any time, for any reason, and their regular NHS care will not be affected in any way.

Locations (2)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Hungary
  • —
    Unverified
    Poland

Common questions

What is OM-85?

OM-85 is a medicine made from broken-down, inactive bacteria that helps train the immune system to fight off chest infections that trigger wheezing.

Will my child definitely receive the real medicine?

No. This is a randomised study, meaning a computer randomly assigns your child to receive either OM-85 or a matching dummy capsule (placebo).

How can my baby or toddler take a capsule?

The capsules are designed so they can be carefully opened and the contents mixed into a small spoonful of food or drink, making it easy for young children to swallow.

Can my child still use their normal inhalers?

Yes. Your child can still use their regular reliever inhalers (such as blue salbutamol) if they need them to help with sudden breathing trouble.

What happens if we decide to stop?

You are free to leave the trial at any point. Deciding to leave will never affect the standard medical care your child receives from the NHS.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "A Randomized, Placebo-Controlled, Double-Blind, Multicenter,…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.